Relay Therapeutics, Inc.
RLAY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $92 | $114 | $94 | $124 |
| Short-Term Investments | $505 | $543 | $617 | $657 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $28 | $24 | $29 | $28 |
| Total Curr. Assets | $624 | $680 | $740 | $809 |
| Property Plant & Equip (Net) | $44 | $46 | $55 | $58 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $2 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $46 | $48 | $60 | $62 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $670 | $729 | $799 | $871 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $8 | $14 |
| Short-Term Debt | $4 | $4 | $6 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $8 |
| Other Curr. Liab. | $26 | $24 | $23 | $23 |
| Total Curr. Liab. | $33 | $33 | $37 | $51 |
| LT Debt | $30 | $31 | $41 | $43 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $30 | $31 | $41 | $43 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $33 | $34 | $47 | $49 |
| Total Liabilities | $62 | $63 | $78 | $94 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,960 | -$1,886 | -$1,815 | -$1,738 |
| AOCI | $0 | -$0 | $0 | -$1 |
| Other Equity | $2,567 | $2,551 | $2,536 | $2,517 |
| Total Equity | $608 | $666 | $721 | $778 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $670 | $729 | $799 | $871 |
| Net Debt | -$58 | -$80 | -$46 | -$76 |